Gene · 51744
Papers3,665
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,665
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Common signatures of neutrophils in diverse disease conditions. | Cell Discov | 2025 | 40744914 | PubTator, text mining | PubMed |
| Engineering Innate Immunity: Recent Advances and Future Directions for CAR-NK and CAR-Macrophage Therapies in Solid Tumors. | Cancers (Basel) | 2025 | 40723278 | PubTator, text mining | PubMed |
| Frailty Assessment and NK Cell Function in Multiple Myeloma: a Comprehensive Analysis. | Clin Lab | 2025 | 40663087 | PubTator, text mining | PubMed |
| VISTA is a potential target for immunotherapy in B-cell acute lymphoblastic leukemia in children. | Sci Rep | 2025 | 40610562 | PubTator, text mining | PubMed |
| Single-cell transcriptomics analysis reveals a disrupted NK-T cell interaction network in liver metastatic cancer. | Sci Rep | 2025 | 40594834 | PubTator, text mining | PubMed |
| Circulating inflammatory proteins as pathogenic mediators and potential therapeutic targets in myasthenia gravis. | Neurol Sci | 2025 | 40569533 | PubTator, text mining | PubMed |
| Altered Expression of NK Receptors in Racially/Ethnically Diverse and Risk-of-Relapse Pediatric Acute Lymphoblastic Leukemia Patients. | Biomedicines | 2025 | 40564131 | PubTator, text mining | PubMed |
| Immunohistochemical Profiling of Immune Checkpoints in Chronic Hepatitis B Liver Tissue. | Pathogens | 2025 | 40559604 | PubTator, text mining | PubMed |
| LAG3 Is Expressed on Muscle-Infiltrating Cytotoxic T Cells, but Scarce on Circulating T Cells, in Patients With Inclusion Body Myositis. | Muscle Nerve | 2025 | 40485502 | PubTator, text mining | PubMed |
| Decoding the maternal-fetal dialogue: NK cell education in reproductive outcomes†. | Biol Reprod | 2025 | 40476707 | PubTator, text mining | PubMed |
| Preventing MSC aging and enhancing immunomodulation: Novel strategies for cell-based therapies. | Regen Ther | 2025 | 40453699 | PubTator, text mining | PubMed |
| scMODAL: a general deep learning framework for comprehensive single-cell multi-omics data alignment with feature links. | Nat Commun | 2025 | 40442129 | PubTator, text mining | PubMed |
| CD49a+ NK cells promote esophageal cancer development by inducing MDCSs infiltration via GM-CSF. | Br J Cancer | 2025 | 40437020 | PubTator, text mining | PubMed |
Harnessing local and system immune profiling delineating differential responders to first-line sintilimab (anti-PD-1 antibody) combined with chemotherapy in extensive-stage small cell lung cancer: an exploratory biomarker analysis of a phase II study. | Signal Transduct Target Ther | 2025 | 40404633 | PubTator, text mining | PubMed |
| Potential therapeutic targets for ovarian hyperstimulation syndrome revealed by proteome-wide mendelian randomization and colocalization analysis. | J Reprod Immunol | 2025 | 40393368 | PubTator, text mining | PubMed |
| Gfi1 controls the formation of effector-like CD8+ T cells during chronic infection and cancer. | Nat Commun | 2025 | 40374625 | PubTator, text mining | PubMed |
| Prospects for γδ T cells and chimeric antigen receptor γδ T cells in cancer immunotherapy. | Front Immunol | 2025 | 40370457 | PubTator, text mining | PubMed |
| The NF-κB signaling network in the life of T cells. | Front Immunol | 2025 | 40370445 | PubTator, text mining | PubMed |
| Insights from bidirectional Mendelian randomization: Evaluating the influence of circulating inflammatory cytokines on prostatitis. | Medicine (Baltimore) | 2025 | 40355178 | PubTator, text mining | PubMed |
| Cytokine Expression and Cytolytic Effect of Natural Killer Cells are Suppressed in Septic Shock. | Scand J Immunol | 2025 | 40254928 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51744/papers?page=5